Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania
Datos Bibliográficos
| ID | 14909557 |
|---|---|
| Autores | Zameer Mohamed (0000-0002-3713-0277, Imperial College London, autor de correspondencia), Nick Scott (0000-0002-9667-2084, Monash University), Shevanthi Nayagam (0000-0002-8030-3380, Imperial College London), John Rwegasha (Muhimbili National Hospital), Jessie Mbwambo (Muhimbili National Hospital), Mark R Thursz, Mark Thursz (0000-0002-8218-192X, Imperial College London), Ashley Brown (0000-0001-6743-3773, Imperial College London), Ashley S Brown, Margaret Hellard (0000-0002-5055-3266, Monash University), Maud Lemoine (0000-0002-9011-2991, Imperial College London) |
| Año | 2022 |
| Volumen | 99 |
| Páginas | 103458 |
| Fecha de publicación | 2022-01-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2021.103458 |
| PMID | 34624732 |
| OpenAlex | W3202201969 |
| Idioma | EN |
| Referencias citadas | 36 |
Cost effectiveness · Dar es salaam · Disease burden · Economic growth · Environmental health · Family medicine · Harm reduction · Health care · Human immunodeficiency virus (HIV · Population · Psychiatry · Psychological intervention · Quality-adjusted life year · Socioeconomics · Tanzania · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Pediatrics
Disability weights for the Global Burden of Disease 2013 study
Mortality among people who inject drugs
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B
Estimating health opportunity costs in low-income and middle-income countries
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Cost-effectiveness model for hepatitis C screening and treatment
The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID)
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania
The investment case for hepatitis B and C in South Africa
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |